EICHOR
● Terminated
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
About this study
This was an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (227)
| MD First Research, LLC Site #767 | Chandler, Arizona, United States | — |
| NoesisPharma, LLC | Phoenix, Arizona, United States | — |
| Perseverance Research Center, LLC | Scottsdale, Arizona, United States | — |
| Health Initiatives Research | Fayetteville, Arkansas, United States | — |
| Advanced Research Center, Inc. Site #835 | Anaheim, California, United States | — |
| ATP Clinical Research, Inc. Site #763 | Costa Mesa, California, United States | — |
| Behavioral Research Specialists, LLC | Glendale, California, United States | — |
| Irvine Center for Clinical Research | Irvine, California, United States | — |
| Sheenath Clinical Service Site #770 | Lakewood, California, United States | — |
| Torrance Clinical Research Institute, Inc. Site #826 | Lomita, California, United States | — |
| Collaborative Neuroscience Network, LLC. | Long Beach, California, United States | — |
| Alliance for Wellness, Inc dba Alliance for Research Site #789 | Long Beach, California, United States | — |
+ 215 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02446132